Details for Patent: 11,154,516
✉ Email this page to a colleague
Which drugs does patent 11,154,516 protect, and when does it expire?
Patent 11,154,516 protects EPIDIOLEX and is included in one NDA.
This patent has forty-eight patent family members in eleven countries.
Summary for Patent: 11,154,516
Title: | Use of cannabinoids in the treatment of epilepsy |
Abstract: | The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of "treatment-resistant epilepsy" (TRE). In particular, the disclosure relates to the use of CBD of treating TRE when the TRE is Dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (FIRES). The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs). |
Inventor(s): | Guy; Geoffrey (Cambridge, GB), Wright; Stephen (Cambridge, GB), Devinsky; Orrin (New York, NY) |
Assignee: | GW Research Limited (Cambridge, GB) |
Application Number: | 17/119,873 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,154,516
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jazz Pharms Res | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE FOR THE TREATMENT OF SEIZURES ASSOCIATED WITH DRAVET SYNDROME | ⤷ Sign Up | ||||
Jazz Pharms Res | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE FOR THE TREATMENT OF SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 11,154,516
International Family Members for US Patent 11,154,516
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2015275886 | ⤷ Sign Up | |||
Australia | 2015275887 | ⤷ Sign Up | |||
Australia | 2020217417 | ⤷ Sign Up | |||
Australia | 2020220135 | ⤷ Sign Up | |||
Australia | 2022202119 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |